As a single mum of four children, Jo Makamaka is juggling many responsibilities. She is not complaining though, just cherishing the opportunity to look after her children and take part in a host of activities which were not always within her reach. Jo first saw a neurologist in her early-20s in response to a collection of unusual symptoms, but it was not until many years later that she was diagnose.....
Read more

To mark World Spine Day on October 16, the Back Pain Research team at the Kolling Institute is urging those who experience the condition to adopt the latest advice and keep moving. Spinal pain is extremely common, affecting around 800 million people globally. The condition compromises social, family and work activities, and is the main reason Australians retire involuntarily. The lower back and nec.....
Read more

A Centre for Research Excellence to improve care for inflammatory arthritis will be based at the Kolling following an exciting announcement by Health Minister Greg Hunt. The minister revealed the latest round of National Health and Medical Research Council funding, which will see $2.5 million invested in the centre and its related projects over the next five years. Professor Lyn March will lead the.....
Read more

The John Walsh Centre for Rehabilitation Research has been awarded close to $10 million to help improve the lives of those living with injury-related disability. The funding has been granted by the state’s compensation agencies icare NSW and the State Insurance Regulatory Authority, continuing a 20 year research partnership. icare NSW Managing Director and CEO Richard Harding said the research was .....
Read more

The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125 were people were admitted to intensiv.....
Read more

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disorders, spinal.....
Read more

New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision. The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford University. Clo.....
Read more

Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program. The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research projects. Cindy is o.....
Read more

Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care. The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care facilities.....
Read more

Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute. The study will further explore the disease modifying effects of Progenza™ and assess its effect in modulating the inflammatory and immune responses in a pre-clinical mode.....
Read more